AstraZeneca’s trial illnesses may not be due to COVID-19 shot: Oxford University

The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted here online by the Oxford University.

https://www.reuters.com/article/us-health-coronavirus-astrazeneca/astrazenecas-trial-illnesses-may-not-be-due-to-covid-19-shot-oxford-univ-idUSKBN2672TV